{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:03:38Z","timestamp":1775250218334,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115318","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:36:02Z","timestamp":1754397362000},"page":"115318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comprehensive evaluation of the PCDHB family in gastric cancer: Prognostic significance, immune infiltration, and experimental validation of PCDHB5's oncogenic role"],"prefix":"10.1016","volume":"163","author":[{"given":"Juanjuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2025.115318_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.intimp.2025.115318_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.31662\/jmaj.2018-0006","article-title":"Update on the treatment of gastric Cancer","volume":"1","author":"Hashimoto","year":"2018","journal-title":"JMA J."},{"issue":"10251","key":"10.1016\/j.intimp.2025.115318_bb0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.intimp.2025.115318_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/CEJ.0000000000000480","article-title":"Gastric cancer: epidemiology, biology, and prevention: a mini review","volume":"28","author":"Lyons","year":"2019","journal-title":"Euro. J. cancer prevention\u202f: the official J. Euro. Cancer Prevention Organisation (ECP)"},{"issue":"7890","key":"10.1016\/j.intimp.2025.115318_bb0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","article-title":"The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer","volume":"600","author":"Janjigian","year":"2021","journal-title":"Nature"},{"issue":"5\u20136","key":"10.1016\/j.intimp.2025.115318_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10585-018-9921-y","article-title":"Cancer initiation and progression within the cancer microenvironment","volume":"35","author":"Leong","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.intimp.2025.115318_bb0035","doi-asserted-by":"crossref","first-page":"1016817","DOI":"10.3389\/fimmu.2022.1016817","article-title":"Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115318_bb0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/2326-6066.CIR-16-0365","article-title":"The tumor microenvironment regulates sensitivity of murine lung Tumors to PD-1\/PD-L1 antibody blockade","volume":"5","author":"Li","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115318_bb0045","first-page":"74","article-title":"Tumor immune microenvironment characterization and response to anti-PD-1 therapy","volume":"12","author":"Santarpia","year":"2015","journal-title":"Cancer Biol. Med."},{"issue":"7528","key":"10.1016\/j.intimp.2025.115318_bb0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2025.115318_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ceb.2007.09.006","article-title":"Protocadherin family: diversity, structure, and function","volume":"19","author":"Morishita","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.intimp.2025.115318_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semcdb.2017.07.007","article-title":"Epigenetic dysregulation of protocadherins in human disease","volume":"69","author":"El Hajj","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115318_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/0008-5472.CAN-16-1267-T","article-title":"PROTOCADHERIN 7 acts through SET and PP2A to potentiate MAPK Signaling by EGFR and KRAS during lung tumorigenesis","volume":"77","author":"Zhou","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115318_bb0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/path.5073","article-title":"Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers","volume":"245","author":"Ye","year":"2018","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115318_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110413","article-title":"Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer","volume":"27","author":"Zhu","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.intimp.2025.115318_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010107","article-title":"FOSB\u2212PCDHB13 Axis disrupts the microtubule network in non-small cell lung Cancer","volume":"11","author":"Ting","year":"2019","journal-title":"Cancers"},{"issue":"27","key":"10.1016\/j.intimp.2025.115318_bb0085","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1038\/s41388-022-02370-2","article-title":"PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma","volume":"41","author":"Liu","year":"2022","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2025.115318_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3892\/ol.2022.13237","article-title":"PCDHB15 as a potential tumor suppressor and epigenetic biomarker for breast cancer","volume":"23","author":"Chiang","year":"2022","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.115318_bb0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13148-022-01364-x","article-title":"Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells","volume":"14","author":"Carrier","year":"2022","journal-title":"Clin. Epigenetics"},{"issue":"10","key":"10.1016\/j.intimp.2025.115318_bb0100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer genome atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.115318_bb0105","series-title":"Survminer: An R Package for Facilitating Survival Analysis in Cancer Research. bioRxiv","author":"Kassambara","year":"2017"},{"key":"10.1016\/j.intimp.2025.115318_bb0110","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.intimp.2025.115318_bb0115","series-title":"R: A Language and Environment for Statistical Computing. In","author":"Team RC","year":"2022"},{"issue":"269","key":"10.1016\/j.intimp.2025.115318_bb0120","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"Database issue","key":"10.1016\/j.intimp.2025.115318_bb0125","first-page":"D808","article-title":"STRING v9.1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.115318_bb0130","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2025.115318_bb0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"10","key":"10.1016\/j.intimp.2025.115318_bb0140","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115318_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115318_bb0150","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"issue":"10","key":"10.1016\/j.intimp.2025.115318_bb0155","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/1759-7714.13163","article-title":"Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature","volume":"10","author":"Wang","year":"2019","journal-title":"Thoracic cancer"},{"key":"10.1016\/j.intimp.2025.115318_bb0160","article-title":"Genomic analysis uncovers the prognostic and immunogenetic feature of Pyroptosis in gastric carcinoma: indication for immunotherapy","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell Devel. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115318_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.intimp.2025.115318_bb0170","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harrell","year":"2015"},{"issue":"7","key":"10.1016\/j.intimp.2025.115318_bb0175","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.115318_bb0180","unstructured":"G Y: enrichplot: Visualization of Functional Enrichment Result. In.; 2022."},{"issue":"5","key":"10.1016\/j.intimp.2025.115318_bb0185","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics\u202f: a journal of integrative Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115318_bb0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.intimp.2025.115318_bb0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC bioinformatics"},{"issue":"3","key":"10.1016\/j.intimp.2025.115318_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031900","article-title":"Insights into the steps of breast Cancer-brain metastases development: tumor cell interactions with the blood-brain barrier","volume":"23","author":"Hamester","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2025.115318_bb0205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","article-title":"Tumor microenvironment characterization in gastric Cancer identifies prognostic and Immunotherapeutically relevant gene signatures","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.115318_bb0210","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"7467","key":"10.1016\/j.intimp.2025.115318_bb0215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2025.115318_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2025.115318_bb0225","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2025.115318_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218359","article-title":"The influence of tumor microenvironment on immune escape of melanoma","volume":"21","author":"Simiczyjew","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2025.115318_bb0235","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol.\u202f: CB"},{"issue":"4","key":"10.1016\/j.intimp.2025.115318_bb0240","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1097\/SLA.0000000000004037","article-title":"Poor clinical outcomes and Immunoevasive contexture in Intratumoral IL-10-producing macrophages enriched gastric Cancer patients","volume":"275","author":"Zhang","year":"2022","journal-title":"Ann. Surg."},{"issue":"7655","key":"10.1016\/j.intimp.2025.115318_bb0245","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2025.115318_bb0250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol."},{"issue":"10294","key":"10.1016\/j.intimp.2025.115318_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2025.115318_bb0260","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.omtn.2021.04.003","article-title":"M(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD","volume":"24","author":"Xu","year":"2021","journal-title":"Molecular therapy Nucleic acids"},{"issue":"5","key":"10.1016\/j.intimp.2025.115318_bb0265","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types","volume":"32","author":"McGrail","year":"2021","journal-title":"Annals of oncol.\u202f: official J. Euro. Soc. Med. Oncol."},{"issue":"Spec 6\/1","key":"10.1016\/j.intimp.2025.115318_bb0270","first-page":"587","article-title":"Genomics and bioinformatics as pillars of precision medicine in oncology","volume":"79","author":"Canzoneri","year":"2019","journal-title":"Medicina"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:17:21Z","timestamp":1757913441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925013098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"alternative-id":["S1567576925013098"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115318","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive evaluation of the PCDHB family in gastric cancer: Prognostic significance, immune infiltration, and experimental validation of PCDHB5's oncogenic role","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115318"}}